TrialCancer medicine2023

A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.

Junting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.